This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woodley, S. L. Articles by Barry, W. H. Search for Related Content PubMed PubMed Citation Articles by Woodley, S. L. Articles by Barry, W. H.

Circulation, Vol 83, 1410-1418, Copyright © 1991 by American Heart Association

ARTICLES

Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes

SL Woodley, M McMillan, J Shelby, DH Lynch, LK Roberts, RD Ensley and WH Barry
Department of Medicine, University of Utah School of Medicine, Salt Lake City.

BACKGROUND. The mechanisms by which ventricular function is altered during cardiac transplant rejection are not well understood. Therefore, an in vitro model system has been developed to facilitate investigation of lymphocyte-mediated myocyte injury. METHODS AND RESULTS. Splenic lymphoid cells were obtained from mice 8-10 days after placement of a vascularized abdominal cardiac allograft and were restimulated in vitro with irradiated donor-type splenocytes for 5 days. Cytotoxic effects of these allogenically stimulated lymphocytes on syngeneic and donor strain fetal cultured myocytes were determined by a 51Cr release assay at different lymphocyte to myocyte ratios. 51Cr release from donor strain myocytes was detectable within 1 hour of exposure, was maximal by 3-5 hours of coincubation with sensitized lymphocytes, and was allospecific. Cell injury manifest by 51Cr release was calcium dependent and was inhibited by pretreatment of lymphocytes with phorbol ester to deplete protein kinase C. Myocyte injury was also prevented by pretreatment of sensitized lymphocytes with anti-Thy 1.2 or anti-CD8 antibody plus complement but not by treatment with anti-CD4 antibody, indicating that CD8+ cytotoxic T cells are involved. Altered myocyte contractile motion preceded myocyte lysis (51Cr release), was characterized by an initial reversible decrease in amplitude of contraction, and was followed by rapid and irregular beating with eventual complete cessation of contraction. Contractile alterations induced by sensitized lymphocytes were inhibited by elimination of CD8+ cells. CONCLUSIONS. Myocyte injury can be produced by sensitized cytotoxic T lymphocytes in vitro and is calcium and protein kinase C dependent. The contractile abnormalities produced appear to be similar to those observed in cardiac transplant patients undergoing rejection, and thus this model system promises to allow investigation of the mechanisms involved.

This article has been cited by other articles:

				P. R. Woldbaek, J. B. Sande, T. A. Stromme, P. K. Lunde, S. Djurovic, T. Lyberg, G. Christensen, and T. Tonnessen Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H708 - H714. [Abstract] [Full Text] [PDF]

				K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF]

				J. T. A. Meij, F. Sheikh, S. K. Jimenez, P. W. Nickerson, E. Kardami, and P. A. Cattini Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H547 - H555. [Abstract] [Full Text] [PDF]

				S. S. Bradrick, E. A. Lieben, B. M. Carden, and J. R. Romero A Predicted Secondary Structural Domain within the Internal Ribosome Entry Site of Echovirus 12 Mediates a Cell-Type-Specific Block to Viral Replication J. Virol., July 15, 2001; 75(14): 6472 - 6481. [Abstract] [Full Text]

				M. Satoh, M. Nakamura, H. Satoh, H. Saitoh, I. Segawa, and K. Hiramori Expression of tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human myocarditis J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1288 - 1294. [Abstract] [Full Text] [PDF]

				K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama Cytokine Gene Expression After Myocardial Infarction in Rat Hearts : Possible Implication in Left Ventricular Remodeling Circulation, July 14, 1998; 98(2): 149 - 156. [Abstract] [Full Text] [PDF]

				W. C. Aird, J. M. Edelberg, H. Weiler-Guettler, W. W. Simmons, T. W. Smith, and R. D. Rosenberg Vascular Bed-specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment J. Cell Biol., September 8, 1997; 138(5): 1117 - 1124. [Abstract] [Full Text] [PDF]

				A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama Amiodarone Inhibits Production of Tumor Necrosis Factor-{alpha} by Human Mononuclear Cells : A Possible Mechanism for its Effect in Heart Failure Circulation, September 2, 1997; 96(5): 1386 - 1389. [Abstract] [Full Text]

				A. Matsumori, K. Ono, R. Nishio, H. Igata, B Pharm, T. Shioi, S. Matsui, Y. Furukawa, A. Iwasaki, Y. Nose, et al. Modulation of Cytokine Production and Protection Against Lethal Endotoxemia by the Cardiac Glycoside Ouabain Circulation, September 2, 1997; 96(5): 1501 - 1506. [Abstract] [Full Text]

				T. Shioi, A. Matsumori, and S. Sasayama Persistent Expression of Cytokine in the Chronic Stage of Viral Myocarditis in Mice Circulation, December 1, 1996; 94(11): 2930 - 2937. [Abstract] [Full Text]

				L. E. Wagoner, L. Zhao, D. K. Bishop, S. Chan, S. Xu, and W. H. Barry Lysis of Adult Ventricular Myocytes by Cells Infiltrating Rejecting Murine Cardiac Allografts Circulation, January 1, 1996; 93(1): 111 - 119. [Abstract] [Full Text]

				S. E. Lipshultz, E. J. Orav, S. P. Sanders, and S. D. Colan Immunoglobulins and Left Ventricular Structure and Function in Pediatric HIV Infection Circulation, October 15, 1995; 92(8): 2220 - 2225. [Abstract] [Full Text]